TMJ Prostheses for Condylar Resorption and Benign Tumors Affecting the Condyle
Total mandibular joint replacement is a clinical strategy to treat severe temporomandibular joint (TMJ) disease. The use of TMJ prostheses was introduced into clinical practice in 1960; however, after approval by the FDA in the 1990s, its use became a regular technique for treating some TMJ diseases. Current TMJ prostheses include a fossa component and a condylar component and can be stock or custom-made. Procedures to implant the prosthesis and replace the TMJ are complex; however, technological improvements in planning have improved the process and outcomes. Despite improved knowledge of TMJ replacement, controversy remains regarding indications and timing of the technique. This narrative review aims to describe the indications, characteristics, and variables in TMJ replacement in clinical conditions related to condylar destruction or condylar overgrowth in the case of benign tumors.
Authors
- Rüdiger Zimmerer (ORCID: https://orcid.org/0000-0002-1859-4324)
- Sérgio Olate (ORCID: https://orcid.org/0000-0001-8153-0676)
- Wenko Smolka (ORCID: https://orcid.org/0000-0002-9655-8951)
- Zachary S. Peacock (ORCID: https://orcid.org/0000-0001-7683-3111)
- Ricky Kumar (ORCID: https://orcid.org/0000-0003-4173-8768)
Institutions
- Universidad de La Frontera (CL)
- The Royal Melbourne Hospital (AU)
- Royal Children's Hospital (AU)
- Harvard University (US)
- Universidade Estadual de Campinas (UNICAMP) (BR)
- LMU Klinikum (DE)
- Massachusetts General Hospital (US)
- University of Tübingen (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Journal of Craniofacial Surgery
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1097/scs.0000000000011756
- Primary Topic
- Oral and Maxillofacial Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00